Skip to content
healthcare.dev
Get a free key

KYMRIAH

NDC 0078-0846, tisagenlecleucel, injection, suspension, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0846
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125646
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0846 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TISAGENLECLEUCEL2000000 1/1

Pharmacologic classes

CD19 Receptor Interactions [MoA]; CD19-directed Chimeric Antigen Receptor [EPC]; CD19-specific Chimeric Antigen Receptor [CS]; Genetically-modified Autologous T Cells [EPC]; Increased T Lymphocyte Activation [PE]; T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]

Package NDCNDC-11Package
0078-0846-19000780846191 INJECTION, SUSPENSION in 1 BAG (0078-0846-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-0846

Use it

Look up 0078-0846 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0846 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0846. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.